大摩前职员开发加密货币衍生产品交易平台
《路透》报道,摩根士丹利前软件开发人员宣布推出加密货币衍生产品交易平台Phemex。报道指,摩根士丹利电子交易指标执行策略的前环球研发主管Jack Tao共同创办该平台,并组织逾30名高级开发人员,包括8名摩根士丹利前高层。
报道指,该平台已进行为期数周的测试,并於11月25日正式开放交易。该平台每秒可处理30万宗易,下单及回应共计需时少於百万分之一秒。平台向零售及机构投资者提供最多100倍杠杆,涉及比特币、以太币及瑞波币合约。有关合约未来将有加密资产以外的抵押品,包括股市指数、利率、外汇、农产品、金融及能源等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.